• Nenhum resultado encontrado

Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial.

N/A
N/A
Protected

Academic year: 2017

Share "Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial."

Copied!
17
0
0

Texto

Loading

Imagem

Fig 1. Patient Flow Through the Trial. Screen failures who were rescreened and failed a second time during the screening period were counted once as screen failures
Table 1. Summary of Patient Demographic and Baseline Characteristics (ITT Population).
Fig 2. Primary Endpoint. Intent-to-treat Population; Responder = patient who had  3 CSBMs and an increase of  1 CSBM from baseline, in the same week, for at least 9 of the 12 treatment-period weeks
Table 2. Efficacy Results During the 12-week Treatment Period (ITT Population).
+3

Referências

Documentos relacionados

A randomized controlled trial of endovascular aneurysm repair versus open surgery for abdominal aortic aneurysms in low to moderate risk patients. Greenberg RK, Chuter TA, Cambria

A randomized controlled trial of endovascular aneurysm repair versus open surgery for abdominal aortic aneurysms in low to moderate risk patients. Greenberg RK, Chuter TA, Cambria

Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis: efficacy and safety results from a Phase II/III randomized controlled study.. Genovese MC, Mease

This double-blind, randomized, placebo-controlled clinical trial is the irst study to evaluate the toxicology and safety of tincture of O. alata in patients with

Assim, e como a maioria dos núcleos em estudo são de re- duzida dimensão, despovoados e com populações envelhe- cidas, torna-se urgente intervir, permitindo a conservação e

Efficacy and safety of Golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trial. Carmona L, Abasolo L, Descalzo

A phase III, randomized, double-blind clinical study comparing SB4, an eta- nercept biosimilar, with etanercept reference product (Enbrel) in patients with moderate to severe

Improvement of negative and positive symptoms in treatment- refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy